NCT06052306
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06052306
Title A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | NLD | ITA | GBR | FIN | CHE | CAN

Facility Status City State Zip Country Details
City of Hope - Duarte Cancer Center Duarte California 91010 United States Details
M Health Fairview Masonic Cancer Clinic - Clinics and Surgery Center Minneapolis Minnesota 55455 United States Details
XCancer Omaha Omaha Nebraska 68130 United States Details
The University of Texas MD Anderson Cancer Center - Texas Medical Center Houston Texas 77030 United States Details
Utah Cancer Specialists Cancer Center - Medical Oncology Salt Lake City Utah 84106 United States Details
Cross Cancer Institute, Clinical Trials Unit Edmonton Alberta T6G 1Z2 Canada Details
BC Cancer - Vancouver Site Vancouver British Columbia V5Z 4E6 Canada Details
Princess Margaret Cancer Centre - University Health Network - Department of Medical Oncology and Hematology Toronto Ontario M5G 2C4 Canada Details
Centre Hospitalier de l'Universite de Montreal (CHUM) Montreal Quebec H2X 3E4 Canada Details
McGill University Health Centre (MUHC) - Research Institute (RI) - McConnell Centre for Innovative Medicine (CIM) Montreal Quebec H4A 3J1 Canada Details
Centre Hospitalier Universitaire de Sherbrooke (CHUS) - Hopital Fleurimont Sherbrooke Quebec J1H 5N4 Canada Details
Kuopio University Hospital, Kuopion yliopistollinen sairaala (KYS) - Syövänhoitokeskus Kuopio Northern Savonia 70210 Finland Details
HUS-Yhtymä, Helsingin yliopistollinen sairaala (HUS) - Syöpäkeskus Helsinki Uusimaa 00029 Finland Details
Docrates Mehiläinen Syöpäsairaala Helsinki Uusimaa FIN-00180 Finland Details
Tampere University Hospital, Tampereen yliopistollinen sairaala (TAYS) - Syöpäkeskus Tampere 33520 Finland Details
CRST Oy - Clinical Research Services Turku Turku 20520 Finland Details
Istituto Europeo di Oncologia s.r.l - Medicina Nucleare Milan 20141 Italy Details
IRCCS Istituto Nazionale Tumori Fondazione Pascale - S. C. Medicina Nucleare e Terapia Metabolica Napoli 80131 Italy Details
Universitair Medisch Centrum Groningen Groningen 9713 GZ Netherlands Details
Erasmus Medisch Centrum Rotterdam 3015 CE Netherlands Details
Sahlgrenska Universitetssjukhuset - Klinisk prövningsenhet Fas I/FIH Gothenburg 41346 Sweden Details
Skånes Universitetssjukhus Lund - Onkologens kliniska forskningsenhet Lund 22185 Sweden Details
Karolinska Universitetssjukhuset - Fas I-enheten Solna CKC Stockholm 17176 Sweden Details
Akademiska Sjukhuset - Fas-I-enheten Uppsala 75185 Sweden Details
Kantonsspital Baden Baden Canton of Aargau 5404 Switzerland Details
Universitätsspital Basel Basel Canton of Basel-City 4056 Switzerland Details
Univestitätsspital Zürich (USZ) Zurich 8091 Switzerland Details
Cambridge University Hospitals NHS Foundation Trust | Addenbrookes Hospital - Clinical Research Centre Cambridge Cambridgeshire CB2 0QQ United Kingdom Details
University College London Hospitals NHS Foundation Trust | University College Hospital - NIHR UCLH Clinical Research Facility London Greater London W1T 7HA United Kingdom Details
The Royal Marsden NHS Foundation Trust | Sutton - Oak Foundation Drug Development Unit Sutton Surrey SM2 5PT United Kingdom Details
The Newcastle upon Tyne Hospitals NHS Foundation Trust | Freeman Hospital - Cancer Trials Research Centre Newcastle upon Tyne Tyne and Wear NE7 7DN United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field